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ABSTRACT 
Objective: The current study was designed to explore the hepatoprotective activity of Phyllanthus niruri (PN) alkaloid fraction in induced hepatitis 
in rats.  
Methods: The rats are divided into 5 groups as per the experimental design. Pre alkaloid treatment of PN was given to the hepatitis rats for 21 d. 
After completion of the treatment, the serum was collected, and biochemical analysis was carried out. The hepatic markers like alanine 
aminotransferase (ALT), aspartate aminotransferase (AST) activities, bilirubin (BL) urea (UR), creatinine (CR) levels are estimated in serum.  
Results: ALT, AST activities, BL, CR levels are increased, and UR levels are decreased in hepatitis rats. However with PN alkaloid fraction pre-
treatment all these hepatic markers significantly (P<0.01) came back to near normal levels. Histopathological studies also prove that PN protected 
the hepatic tissue from hepatitis.  
Conclusion: The outcome of the present study showed that the alkaloid fraction of PN possesses hepatoprotective effect in hepatitis rats.  
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INTRODUCTION 
Hepatitis remains as a clinical challenge and a problem of great 
importance. Hepatitis can have serious health effects including 
mortality. There is no specific treatment for hepatitis. According to 
World Health Organisation (WHO) report, more than 600,000 
peoples die each year due to hepatitis [1]. There are many models 
and many chemicals for inducing hepatitis in rats. Chemicals like 
CCL4, D-galactosamine (D-GalN) and others. D-GalN induced liver 
damage is very similar to human viral hepatitis in its morphological 
and functional features [2]. Hence in this study, we used D-
galactosamine for the induction of hepatitis in rats.  
Phyllanthus niruri is one of the most important medicinal plants 
belongs to Phyllanthaceae family. PN has many bioactive compounds, 
which possesses pharmacological properties. PN shows antioxidant, 
antimicrobial and other pharmacological properties [3-5].  
Until know, there was no literature on the effect of an alkaloid fraction 
of PN on hepatic stress markers in hepatitis rats. Hence, the present 
study was designed to explore the hepatoprotective effect of an 
alkaloid fraction of PN in D-galactosamine induced hepatitis in rats.  
MATERIALS AND METHODS 
Plant material collection 
5 Kilograms of Phyllanthus niruri was locally collected in the month 
of October and November 2014 at seven hills, Tirupati, Andhra 
Pradesh, India, Identified and authenticated by botany taxonomist, 
Dr. Madhava Chetty, Department of Botany, S. V. University. A 
voucher specimen No.2151 was retained in the Department of 
Botany, S. V. University, Tirupati. The plant material was washed 
with water and rinsed with sterile distilled water; shade dried and 
powdered using a mechanical grinder. The Alkaloid fraction of PN 
was extracted by using method Houghton and Raman [6]. Of 5 Kilo 
grams of Phyllanthus niruri, we got only 10grms of the alkaloid 
fraction. The alkaloid fraction was stored in air tight container and 
maintained at 4◦C in a refrigerator. 
Chemicals 
All the chemicals are obtained from Sigma, Fisher Scientific 
(Pittsburg, PA, USA), Merck (Mumbai, India), Ranbaxy (New Delhi, 
India) and Qualigens (Mumbai, India). 
Animals and experimental design 
Male Wistar rats (180±200 g) are obtained from Indian Institute of 
Science (IISc), Bangalore. The animals were kept under standard 
laboratory conditions (temperature (27±2 ºC), natural light-dark 
cycle (photoperiod of 12 h light and 12 h), and humidity 55–60%. 
The rats were maintained on a standard pellet diet (M/s Hindustan 
Lever Ltd., Mumbai) and provided access to water ad libitum. The 
study design was approved by the animal ethical committee 
(Resolution No.10/08/a/CPCSCA/IAEC/SVU/09-10/ZOOL/KRS/ 
Dt.25.09.2009). After 7 d of acclimatization, animals were divided 
into five groups of six rats in each group. 
Group I Normal Control (NC): rats received saline for 21 d and 
served as normal control. 
Group II Alkaloid Fraction treatment (AFt): rats were given an 
alkaloid fraction of Phyllanthus niruri (100 mg/kg b/w) for 21 d. 
Group III Hepatitis Control (HC): A single injection of D-
galactosamine (800 mg/kg b/w) was given intraperitoneally for the 
induction of hepatitis 48 h before sacrifice.  
Group IV Hepatitis+Alkaloid Fraction treatment (H+Aft): Pre-
treatment of an alkaloid fraction of Phyllanthus niruri was 
administered orally for 21 d and a single injection D-galactosamine 
(800 mg/kg b/w) was given intraperitoneally for the induction of 
hepatitis 48 h before sacrifice. 
Group V Hepatitis+Silymarin treatment (H+St): Pre-treatment of 
standard drug silymarin (100 mg/kg b/w) was administered orally 
for 21 d and a single injection of D-galactosamine (800 mg/kg b/w) 
was given intraperitoneally for the induction of hepatitis 48 h before 
sacrifice. 
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After 21 d of treatment, all the rats were sacrificed, and blood 
samples were collected. Serum was separated and was frozen at-
80oC until further analysis.  
Estimation of hepatic markers  
Aspartate aminotransferase (AST), alanine aminotransferase (ALT), 
bilirubin (BL), urea (UR), creatinine (CR) are measured in serum by 
using commercially available kits following the manufacturer´s protocol. 
Histopathological studies 
The liver tissues were fixed for 48 h in 4% paraformaldehyde, were  
dehydrated by passing them successively in different mixtures of 
ethyl alcohol-water, cleaned in xylene, and embedded in paraffin. 
Sections of the liver (3µ thick) were prepared, stained with 
haematoxylin and eosin (H&E 10×), and mounted using neutral 
(DPX) mountant for microscopic observation. 
Statistical analysis 
Results are expressed as means±standard deviation (SD). Variance 
analysis was done with Duncan’s multiple comparison tests among 
data were carried out using the SPSS (Version 15; SPSS Inc., Chicago, 
IL, USA) and M. S. Office, excel software for the significance of the 
main effects (factors), and treatments along with their interactions. 
Statistical significance was set at P<0.01. The p-values are presented 
with obtained data. 
RESULTS  
In the current study, we reported that in hepatitis rats, Aspartate 
aminotransferase, alanine aminotransferase activities are increased in 
hepatitis rats. However, with PN alkaloid fraction supplementation in 
hepatitis rats, we observed decreased activities of Aspartate 





Fig. 1: Effects of an alkaloid fraction of Phyllanthus niruri 
and silmyrin on AST & ALT, activities in the serum of normal 
and hepatitis rats. Data are expressed as means±SD (n = 6). * 
The values are significant compared to the following: 
control (* p<0.001), hepatitic (*p<0.01) (Dunnett’s multiple 
comparison test) 
Bilirubin, creatinine levels increased, and urea levels decreased in 
hepatitis rats. However treatment with an alkaloid fraction of 
Phyllathus niruri in hepatitis rats, bilirubin, and creatinine levels 
decreased significantly (P<0.01) during hepatitis rats. Whereas Urea 
levels increased with an alkaloid fraction of Phyllathus niruri in 







Fig. 2: Effects of an alkaloid fraction of Phyllanthus niruri 
and silmyrin on BL, UR and CR levels in the serum of normal 
and hepatitis rats. Data are expressed as means±SD (n = 6). * 
The values are significant compared to the following: 
control (* p<0.001), hepatitic (*p<0.01) (Dunnett’s multiple 
comparison tests) 
 
In the Current study, in normal control rats, we observed normal 
central vein, normal hepatocytes, and normal sinusoids. But in 
Hepatitis rats, degeneration of central vein (DCV), degeneration 
hepatocytes (DHC) and degeneration sinusoids (DSS) are seen. 
However, with PN supplementation in hepatitis rats these hepatic 
cells like central vein (RCV), hepatocytes (RHC) and sinusoids (RSS) 
are regenerated. 
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Fig. 3: Effect of PN on liver tissue during hepatitis condition 
 
DISCUSSION 
In the present study, we reported that AST and ALT activities are 
increased in hepatitis rats. The increase in serum AST and ALT 
activities is in agreement with the findings [7] who found that AST 
and ALT activities of rats were significantly increased in hepatitis 
[7]. The marked rises in serum levels of ALT, AST, due to the damage 
to the plasma and disturbance in the transport functions of 
hepatocytes, are circulating markers of lipid peroxidation 
substances (LPS) induced hepatocyte injury. However, the alkaloid 
fraction of PN supplementation reduced AST & ALT activities 
significantly (P<0.01) in hepatitis rats. This may be due to the 
hepatoprotective activity of PN (fig. 1). 
Bilirubin is one of the important stress marker levels. Serum 
bilirubin serves as an index for the assessment of hepatic function, 
and any abnormal increase in the levels of bilirubin in the serum 
indicate hepatobiliary disease and severe disturbance of 
hepatocellular function. In this study, we reported that BL levels 
increased in hepatitis rats. The increase in the levels of bilirubin in 
the serum indicates hepatis tissue damage and disturbance of 
hepatocellular function. The increased levels of bilirubin could result 
from an impairment of uptake or conjugation coupled with 
decreased excretion of bilirubin. Increased levels of bilirubin in this 
study are in agreement with the reports of the previous studies that 
D-GalN-induced hepatitis is characterized by increased levels of 
bilirubin in serum [8]. However, PN supplementation suppressed 
the increased bilirubin levels significantly (P<0.01) in hepatitis 
rats (fig. 2). 
Creatinine is one of the most important stress markers. Elevated 
levels of serum creatinine can be attributed to the increased 
breakdown of creatine phosphate for energy and conversion of 
creatine to creatinine for excretion. [9] The restoration of the above 
parameters to near normal in alkaloid fraction of PN pretreated 
group could be due to the antioxidant defense of PN that stabilizes 
the liver function and contributes to its hepatoprotective effect [3] 
(fig. 2).  
In our study, we observed low levels of UR in hepatitis rats. During 
hepatitis condition serum urea declines significantly due to the 
failure of the liver to convert amino acids and ammonia to urea. 
Several studies have reported decreased levels of urea during d-
GalN-induced hepatitis in rats [9,10]. The results of our study were 
similar with the above findings. Urea production is related to 
metabolic pathways for disposal of ammonia, which is the toxic end 
product of nitrogen metabolism [11], have suggested that 
stoichiometric amounts of aspartate and carbamoyl phosphate are 
required for proper functioning of the urea cycle. Thus, the 
reduction in the level of urea may be due to the interference of d-
GalN/lPS with the control mechanisms, which regulate the 
stoichiometric formation of these compounds. Alteration in the level 
urea is potential markers of free radical damage to protein.  
There is an increased catabolism of proteins coupled with the 
diminished ability of kidneys to excrete nitrogenous waste. This 
could possibly account for the lowered urea levels in the serum of d-
GalN-induced rats. However with an alkaloid fraction of PN, urea 
levels increased significantly (P<0.01) in hepatitis rats. This may be 
due to the hepatoprotective activity of PN (fig. 2). 
In the present study, we observed normal central vein, normal 
heptocytes and normal sinusoids in the liver of normal control rats. 
Whereas in Hepatitis rats, we observed degeneration of central vein 
(DCV), degeneration heptocytes (DHC) and degeneration sinusoids 
(DSS). However, with PN treatment in hepatitis rats, central vein 
(RCV), heptocytes (RHC) and sinusoids (RSS) regenerated. This 
shows the hepatoprotective activity of Phyllanthus Niruri in 
hepatitis rats. The bioactive and pharmacological compounds of PN 
in alkaloid fraction may protect the hepatic tissue from hepatitis 
rats. (fig. 3). 
CONCLUSION 
This is first reported data on the hepatoprotective effect of an 
alkaloid fraction of PN during hepatitis condition. In the current 
study, we reported that alkaloid fraction isolated from Phyllanthus 
niruri shows a hepatoprotective effect against hepatitis in rats. But, 
the mechanism of its protective action is not clearly known. Further 
studies are, therefore, needed to know the mechanism and other 
related metabolic pathways alterations by an alkaloid fraction of PN 
in hepatitis condition.  
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